|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.6950 EUR | +14.50% |
|
+10.86% | -52.86% |
| 07-13 | AB Science to Discontinue Three Masitinib-related Clinical Studies | MT |
| 07-10 | AB Science streamlines its portfolio and refocuses on two molecules |  |
Chart: Technical Analysis
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- AB Stock
- A8D Stock
- Charts AB Science
Select your edition
All financial news and data tailored to specific country editions
